The Distribution of Cardiovascular-Related Comorbidities in Different Adult-Onset Cancers and Related Risk Factors: Analysis of 10 Year Retrospective Data
- PMID: 34595215
- PMCID: PMC8476781
- DOI: 10.3389/fcvm.2021.695454
The Distribution of Cardiovascular-Related Comorbidities in Different Adult-Onset Cancers and Related Risk Factors: Analysis of 10 Year Retrospective Data
Abstract
Introduction: Understanding the epidemiology of cardiovascular disease (CVD) related comorbidity is a key strategy for improving the outcomes of patients with cancer. Therefore, this study aimed to assess the distribution of cardiovascular comorbidities and cardiovascular risk factors (CVRF) among five cancer sites. Methods: This is a single-centered, cross-sectional study performed in Dalian, China. Between 2008 and 2018, all newly diagnosed cancer in the First Affiliated Hospital of Dalian Medical University, China were screened. Clinical data were extracted from a comprehensive electronic health record system. Results: 35861 patients with lung, colorectal, gastric, breast, and thyroid cancer were collected retrospectively. The most prevalent CVDs in descending order were hypertension (21.9%), followed by coronary heart disease (6.5%), atrial fibrillation (2.9%), and heart failure (1%). The prevalence of hypertension significantly varies between lung (21.3%), colorectal (27.3%), gastric (22.5%), breast (16.7%), and thyroid cancer (22.4%) (P < 0.001). CVRF varies with cancer sites. Age, sex, total cholesterol, triglyceride, low-density lipoprotein cholesterol, systolic blood pressure, smoking, alcohol use, and diabetes mellitus (DM) are common risk factors associated with CVD at different cancer sites. The association between DM and presence of CVD was strong in breast (odds ratio [OR] = 4.472, 95% confidence interval [CI]: 3.075-6.504, P < 0.001), lung (OR = 3.943; 95% CI: 3.270-4.754, P < 0.001), colorectal (OR = 3.049; 95% CI: 2.326-3.996, P < 0.001), and gastric (OR = 2.508; 95% CI: 1.927-3.264, P < 0.001) cancer. Conclusion: Cancer patients had a significant burden of CVD and increased CVRF. The prevalence of CVRF and CVD comorbidity differ for cancer types. DM remains significantly associated with CVD at different cancer sites except for thyroid cancer.
Keywords: cancer; cardiovascular diseases; diabetes mellitus; hypertension; risk factors.
Copyright © 2021 Li, Liu, Tang, Lee, Lang, Bai and Xia.
Conflict of interest statement
CL and LB was employed by the company Yidu Cloud Technology, Ltd., Beijing, China. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Postmenopausal Women with Breast, Endometrial, and Ovarian Cancers Have an Increased Risk for Cardiovascular Conditions prior to Active Endocrine Therapy.Oxid Med Cell Longev. 2022 Aug 22;2022:5104351. doi: 10.1155/2022/5104351. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36046689 Free PMC article.
-
Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.J Korean Med Sci. 2021 Jan 11;36(2):e15. doi: 10.3346/jkms.2021.36.e15. J Korean Med Sci. 2021. PMID: 33429474 Free PMC article.
-
Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.J Am Acad Nurse Pract. 2009 Mar;21(3):140-8. doi: 10.1111/j.1745-7599.2008.00377.x. J Am Acad Nurse Pract. 2009. PMID: 19302689
-
Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.Heart Fail Rev. 2019 Nov;24(6):989-995. doi: 10.1007/s10741-019-09808-y. Heart Fail Rev. 2019. PMID: 31175492 Review.
-
Comorbidity complicates cardiovascular treatment: is diabetes the exception?Neth J Med. 2012 Sep;70(7):298-305. Neth J Med. 2012. PMID: 22961822 Review.
Cited by
-
Atrial fibrillation and breast cancer-Vicious twins? A systematic review and meta-analysis.Front Cardiovasc Med. 2023 Mar 10;10:1113231. doi: 10.3389/fcvm.2023.1113231. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36970342 Free PMC article.
-
Cardiovascular mortality risk in patients with ovarian cancer: a population-based study.J Ovarian Res. 2024 Apr 25;17(1):88. doi: 10.1186/s13048-024-01413-4. J Ovarian Res. 2024. PMID: 38664732 Free PMC article.
-
Postmenopausal Women with Breast, Endometrial, and Ovarian Cancers Have an Increased Risk for Cardiovascular Conditions prior to Active Endocrine Therapy.Oxid Med Cell Longev. 2022 Aug 22;2022:5104351. doi: 10.1155/2022/5104351. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36046689 Free PMC article.
-
Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiac Events Among Hospitalized Patients with Blood Cancers.Cancer Control. 2025 Jan-Dec;32:10732748251332803. doi: 10.1177/10732748251332803. Epub 2025 Apr 17. Cancer Control. 2025. PMID: 40243279 Free PMC article.
-
Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression.Sci Rep. 2023 Apr 6;13(1):5662. doi: 10.1038/s41598-023-31575-y. Sci Rep. 2023. PMID: 37024569 Free PMC article.
References
-
- Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TA, et al. . Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. (2019) 20:1493–505. 10.1016/S1470-2045(19)30456-5 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources